Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival.

McArdle CS, McMillan DC, Greenlaw N, Morrison DS.

BMC Cancer. 2010 Jul 30;10:398. doi: 10.1186/1471-2407-10-398.

2.

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.

J Natl Cancer Inst. 2005 Jan 19;97(2):116-26.

PMID:
15657341
3.

Long-term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer.

Pinnarò P, Rambone R, Giordano C, Giannarelli D, Strigari L, Arcangeli G.

Am J Clin Oncol. 2011 Jun;34(3):238-44. doi: 10.1097/COC.0b013e3181dea9b8.

PMID:
20805741
4.
5.
6.
7.

Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.

Shapiro CL, Gelman RS, Hayes DF, Osteen R, Obando A, Canellos GP, Frei E 3rd, Henderson IC.

J Natl Cancer Inst. 1993 May 19;85(10):812-7.

PMID:
8487326
8.

Ten-year outcome after combined modality therapy for inflammatory breast cancer.

Harris EE, Schultz D, Bertsch H, Fox K, Glick J, Solin LJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1200-8. Review.

PMID:
12654428
9.

Postmastectomy radiotherapy and concomitant adjuvant chemotherapy versus adjuvant chemotherapy alone in premenopausal breast cancer patients with positive axillary nodes.

Micheletti E, La Face B, Huscher A, Catalano G, Ambrosi E, Marini G, Simoncini E.

Tumori. 1998 Nov-Dec;84(6):652-8.

PMID:
10080670
10.

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results.

Rouëssé J, de la Lande B, Bertheault-Cvitkovic F, Serin D, Graïc Y, Combe M, Leduc B, Lucas V, Demange L, Nguyen TD, Castèra D, Krzisch C, Villet R, Mouret-Fourme E, Garbay JR, Noguès C; Centre René Huguenin Breast Cancer Group.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1072-80.

PMID:
16504757
11.

Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term results.

Colozza M, Gori S, Mosconi AM, Anastasi P, de Angelis V, Giansanti M, Mercati U, Aristei C, Latini P, Tonato M.

Am J Clin Oncol. 1996 Feb;19(1):10-7.

PMID:
8554028
12.

Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.

Colleoni M, Price K, Castiglione-Gertsch M, Goldhirsch A, Coates A, Lindtner J, Collins J, Gelber RD, Thürlimann B, Rudenstam CM.

Eur J Cancer. 1998 Oct;34(11):1693-700.

PMID:
9893654
13.

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.

Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P, et al.

Clin Cancer Res. 1995 Feb;1(2):189-98.

14.

Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.

Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L; Cancer and Leukemia Group B.

J Clin Oncol. 2003 May 1;21(9):1825-35. Erratum in: J Clin Oncol. 2003 Dec 1;21(23):4469.

PMID:
12721260
15.

Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.

Lamb D, Atkinson C, Joseph D, O'Brien P, Ackland S, Bonaventura A, Dady P, Hamilton C, Spry N, Stewart J, Denham J.

Australas Radiol. 1999 May;43(2):220-6.

PMID:
10901906
16.

Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.

Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J; Anglo-Celtic Cooperative Oncology Group.

J Natl Cancer Inst. 2004 Jul 21;96(14):1076-83.

PMID:
15265969
18.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
19.
20.

Supplemental Content

Support Center